Novo Nordisk Shanghai and ShanghaiPharmaceutical Holdings sign a contract to make another breakthrough incooperation

(hereinafter referred to as "NovoNordisk Shanghai") and Shanghai Pharmaceutical Holdings Limited(hereinafter referred to as "Shanghai Pharmaceutical Holdings") helda strategic cooperation signing at the 5th China International Import Expo.

　　Shanghai Pharmaceutical Holdings willprovide Novo Nordisk Shanghai with an intelligent modern logistics warehousethrough innovative pharmaceutical third-party logistics services, and furthermeet Novo Nordisk Shanghai's future business development needs with intensive,standardized, informationized and intelligent pharmaceutical logisticsmanagement and operations, and help Novo Nordisk better serve Chinese patients.

　　Zhang Qing, deputy director of ShanghaiPharmaceutical Regulatory Bureau, said that this cooperation is fullyinnovative, forward-looking and exemplary, which is a useful exploration forShanghai Pharmaceutical Holdings to participate in the global medical businessin collaboration with industry partners and integrate into the internationaland domestic double cycle, and is also an important initiative to help Shanghaifurther play a leading role in the biopharmaceutical industry and acceleratethe construction of a biopharmaceutical industry innovation highland withinternational influence.

　　Zhang Qing hoped that ShanghaiPharmaceutical Holdings and Novo Nordisk would make the cooperation project abright business card of the new Lingang area and contribute to the promotion ofa new round of high-quality development of Shanghai's biopharmaceuticalindustry.

　　Li Yongzhong, Executive Director and VicePresident of Shanghai Pharmaceutical and General Manager of ShanghaiPharmaceutical Holdings, said that in the past 20 years, ShanghaiPharmaceutical Holdings has participated in several heavyweight products ofNovo Nordisk. These efforts have made the cooperation between the two partieshas been growing steadily. The signing of this strategic cooperation will be aninnovative breakthrough for both parties in pharmaceutical tri-party logistics.